Research Topic · Peer-Reviewed

Competitive Analysis of Drugs

In the highly competitive pharmaceutical industry, drug companies must constantly monitor their competitors to stay ahead of the game. This process, known as competitive analysis, involves gathering information on rival products and businesses to gain a better understanding of the competitive landscape. One of the …

Curated from this journal's research 📚 1 peer-reviewed article cited Cited 11× across the literature 🔖 ISSN 2328-0182 🗓 Reviewed July 2026

Overview

In the highly competitive pharmaceutical industry, drug companies must constantly monitor their competitors to stay ahead of the game. This process, known as competitive analysis, involves gathering information on rival products and businesses to gain a better understanding of the competitive landscape. One of the main goals of pharmaceutical competitive analysis is to identify strengths and weaknesses of other drugs on the market. This information can be used to develop strategies to capitalize on your own products' strengths and weaknesses, as well as to identify opportunities to improve or differentiate your drug from the competition. Another key aspect of competitive analysis in pharmaceuticals is market research. This involves gathering data on current market trends, consumer preferences, and other factors that might impact the success of a product. By staying up-to-date on industry trends and consumer demand, companies can make informed decisions about how to position their products in the market. Additionally, competitive analysis in pharmaceuticals requires a deep understanding of the regulatory landscape. Drug companies must navigate complex regulations and processes before they can release a new product to the public. By staying on top of regulatory changes and guidelines, companies can ensure that they are in compliance with all relevant laws and regulations. Overall, competitive analysis is a critical component of success in the pharmaceutical industry. By gathering information on competitors, staying up-to-date on market trends, and navigating the regulatory landscape, drug companies can position themselves to succeed in an ever-evolving industry.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

How this research is being cited

The 1 article above has been cited 11 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.

A sample of recent works citing this journal's research on Competitive Analysis of Drugs, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Advanced Pharmaceutical Science And Technology (ISSN 2328-0182).

Journal editorial board
natalia malara · Italy Saba Khalilpour · Italy Haseeb Khan · United States

This page summarises published research for orientation; it is not medical or professional advice.